Cannabis Wire
Cannabis offers a wealth of opportunities for in-depth journalism. It lies at the crossroads of health, science, and exciting medical innovations. Additionally, it is part of a rapidly growing billion-dollar market, prompting important discussions around regulation, technology, legal issues, criminal justice, and personal freedoms. The publication, Cannabis Wire, aims to explore these complex questions in depth.
Outlet metrics
Global
#6155087
United States
#1849040
News and Media
#28364
Articles
-
1 week ago |
cannabiswire.com | Nushin Rashidian
California lawmakers have introduced nearly a dozen cannabis and hemp bills this legislative session, and two issues are in the spotlight: tax relief, and intoxicating hemp. Don’t miss out. Subscribe now for instant access. Save time with reporting on cannabis policy, regulation, and research – from journalists with more than a decade of subject-matter expertise. Email [email protected] for team and non-profit rates.
-
3 weeks ago |
cannabiswire.com | Nushin Rashidian
Just as Thursday’s Cannabis Control Board meeting got going, it was interrupted by an exasperated applicant awaiting license approval. After Board Chair Tremaine Wright welcomed attendees and turned to the day’s agenda, which ranged from business license approvals to updates on sales and ongoing trade practice investigations, an audience member interjected. “We have been patiently waiting for a year and a half,” she said, in reference to the application window that closed in December 2023.
-
1 month ago |
cannabiswire.com | Nushin Rashidian
Hemp briefly took the spotlightduring a House committee hearing on Wednesday that was focused on cutting what Republicans say is excessive red tape at the U.S. Food and Drug Administration. Don’t miss out. Subscribe now for instant access. Save time with reporting on cannabis policy, regulation, and research – from journalists with more than a decade of subject-matter expertise. Email [email protected] for team and non-profit rates.
-
1 month ago |
cannabiswire.com | Alyson Martin
After two years of steady progress, the cannabis rescheduling process that former Pres. Joe Biden initiated in late 2022 came to a grinding halt in January.
-
1 month ago |
cannabiswire.com | Nushin Rashidian
At the New York Cannabis Control Board meeting on Thursday, regulators proposed a slow down of cultivation licensing and loosening restrictions on retailers who want to offer cannabis discounts. They also lifted the hood for the first time on some trade investigations underway. Don’t miss out. Subscribe now for instant access. Save time with reporting on cannabis policy, regulation, and research – from journalists with more than a decade of subject-matter expertise.
Cannabis Wire journalists
Contact details
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →